Latest News

  • INVESTMENT

    6 Apr 2026

    RNA Gets a $2.4B Promotion at Eli Lilly

  • PARTNERSHIPS

    31 Mar 2026

    RNA Meets Cell Therapy, and Texas Is Holding the Handshake

  • REGULATORY

    26 Mar 2026

    No Trial? No Problem. FDA Rewrites the RNA Rules

  • INVESTMENT

    23 Mar 2026

    New Funding Backs Precision in mRNA Medicine

Fatty Bubbles and the $2.25 Billion Peace

Red Moderna logo signage mounted on building exterior above entrance

PARTNERSHIPS

17 Mar 2026

Moderna settles landmark LNP patent dispute for up to $2.25B, securing a royalty-free delivery license for its infectious disease vaccine programs

mRNA vaccine vial on medical documents with pills, syringe, and stethoscope

MARKET TRENDS

5 Feb 2026

mRNA Deals Push the Industry Beyond Vaccines

Big acquisitions and delivery breakthroughs signal mRNA’s shift from pandemic speed to precision therapies

BioNTech and CureVac company branding displayed outside offices

PARTNERSHIPS

3 Feb 2026

BioNTech–CureVac Deal Marks a New Era for mRNA

BioNTech’s CureVac buyout shows how scale and integration are now driving competition in the mRNA industry

Biotech executives mark a major corporate milestone during a Nasdaq ceremony

PARTNERSHIPS

20 Jan 2026

GSK’s $2.2B Bet Signals a New Phase in Allergy Drug Races

GSK’s acquisition of RAPT spotlights late-stage allergy drugs, hints at a cautious M&A revival, and raises the stakes in immunology

Bristol Myers Squibb corporate sign outside company campus

INSIGHTS

19 Jan 2026

BMS–Orbital Deal Signals a Sharper Bet on In Vivo RNA

Bristol Myers Squibb’s Orbital buy shows how big pharma is methodically building RNA muscle beyond vaccines

Merck and Moderna logos displayed on a white background

RESEARCH

16 Jan 2026

mRNA Developers Regroup After Trial Setbacks

After late-stage failures, mRNA leaders narrow pipelines, double down on vaccines and cancer, and adopt tougher capital discipline

Oncovita company logo linked to RNA oncology drug development

PARTNERSHIPS

13 Jan 2026

AI Alliance Refines RNA Cancer Drug Discovery

Oncovita teams with Infinitusbio.AI to use digital cell modeling to sharpen early decisions in RNA oncology research

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.